The mechanism may be through increasing the expression of estrogen receptor β (ERβ) in renal cell carcinoma, and the expression of ERβ is closely related to the clinical prognosis and immunotherapy response of renal cell carcinoma [32]. The gene discussed is ESR2; the disease is renal cell carcinoma.